Neuraxis completes stock option exchange; grants RSUs to execs and directors

Neuraxis, INC

Stock Option Exchange effective July 24, 2026: 1,319,394 options cancelled for equivalent RSUs on one-for-one basis.
From exchange: CEO Brian Carrico 199,188 RSUs; CMO Adrian Miranda 199,106; CRO Thomas Carrico 193,678, vesting immediately.
On Aug 13, 2026: new RSU grants to CEO 193,329, CFO Timothy Henrichs 141,479, CMO 133,341, CRO 135,906, vesting over 3 years.
One-time equity awards of 127,120 shares to independent directors on Aug 13, 2026, after comp consultant review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.